| Expression pattern: |
UP |
| Associated gene: |
S100A1, Beclin1, p62 |
| Associated microRNA: |
miR-6893 |
| Biological function: |
Promotes cervical cancer tumorigenesis, tumor growth, migration, invasion and cisplatin chemoresistance; inhibits cisplatin-induced apoptosis. |
| Molecular mechanism: |
circMTO1 acts as a ceRNA for miR-6893, regulating S100A1 and autophagy signaling to promote tumorigenesis and chemoresistance in cervical cancer. |
| Biological pathway or process: |
ceRNA regulation (promotes); autophagy (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); drug resistance (promotes); chemoresistance (promotes); other pathway/process (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
RT-qPCR; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; Wound Healing Assay; Transwell Assay; MTT; TUNEL; Western Blot; In Vivo Animal Model |
| Clinical significance: |
Potential therapeutic target and biomarker for cervical cancer. |
| Description: |
circMTO1 is up-regulated in cervical cancer cells and tumors. It promotes cervical cancer migration, invasion, tumor growth and cisplatin chemoresistance by sponging miR-6893 and regulating S100A1 and autophagy-related signaling. The study suggests circMTO1 may serve as a therapeutic target and biomarker for cervical cancer. |
| Confidence score: |
0.5634 |